INVIRAGEN, INC.

Profile

Company Names

INVIRAGEN, INC.

Addresses

1613 PROSPECT PARKWAY, SUITE 100, FORT COLLINS, CO 80525

2619 MIDPOINT DRIVE, SUITE A, FORT COLLINS, CO 80525

Phone Numbers

970-372-4754
970-672-4918

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$15,307,459.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2009-09-22 
$15,307,459.00 
$15,307,459.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HENG 
TONG 
CHOO 
DIRECTOR
INVIRAGEN, INC.
JOHN 
 
NEIS 
DIRECTOR
INVIRAGEN, INC.   |  VIRENT ENERGY SYSTEMS INC   |  NOVELOS THERAPEUTICS, INC.   |  CELLECTAR BIOSCIENCES, INC.   |  GREAT LAKES PHARMACEUTICALS, INC.   |  DELPHINUS MEDICAL TECHNOLOGIES, INC.   |  TAI DIAGNOSTICS, INC.   |  VENTURE INVESTORS HEALTH FUND 6 LIMITED PARTNERSHIP   |  HEALTH SCHOLARS, INC.   |  VENTURE INVESTORS HEALTH FUND 7 LIMITED PARTNERSHIP
REX 
R. 
O-NEAL 
EXECUTIVE OFFICER
INVIRAGEN, INC.
JORGE 
 
OSORIO 
EXECUTIVE OFFICER, PROMOTER
INVIRAGEN, INC.
JERRY 
 
SADOFF 
DIRECTOR
INVIRAGEN, INC.
FRED 
 
SCHWARZER 
DIRECTOR
INVIRAGEN, INC.   |  KEREOS, INC   |  HEALTH FIDELITY, INC.   |  GREAT LAKES PHARMACEUTICALS, INC.   |  MIRABILIS MEDICA INC   |  MIRABILIS MEDICA, INC.   |  MULTIVALENT BIOTHERAPIES, INC.
DAN 
 
STINCHCOMB 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
INVIRAGEN, INC.   |  FLUGEN INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-01-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
2010-10-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
2009-10-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
2009-10-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#